OCATA THERAPEUTICS, INC. (OCAT) financial statements (2021 and earlier)

Company profile

Business Address 33 LOCKE DRIVE
MARLBOROUGH, MA 01752
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
12/31/2014
Q4
9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments323244844
Cash and cash equivalents323244844
Receivables  0000 
Prepaid expense    000
Other undisclosed current assets0000001
Total current assets:333245855
Noncurrent Assets
Property, plant and equipment1111111
Prepaid expense0000000
Other undisclosed noncurrent assets0000000
Total noncurrent assets:1111111
TOTAL ASSETS:333356966
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4434466
Accounts payable2211233
Accrued liabilities2223233
Debt0     1
Derivative instruments and hedges, liabilities8110000 
Estimated litigation liability  12234
Deferred revenue and credits0000000
Other undisclosed current liabilities(8)(10)(0)(0)(0)(0)14
Total current liabilities:55467924
Noncurrent Liabilities
Liabilities, other than long-term debt1222222
Deferred revenue and credits1222222
Other undisclosed noncurrent liabilities141111000
Total noncurrent liabilities:151233222
Total liabilities:20177891126
Stockholders' equity
Stockholders' equity attributable to parent, including:1416(2)(3)1(6)(21)
Common stock0000033
Additional paid in capital381380354346343360334
Accumulated deficit(367)(363)(356)(349)(342)(338)(323)
Warrants and rights outstanding81100000
Other undisclosed stockholders' equity attributable to parent(8)(11)(0)(0)(0)(32)(35)
Total stockholders' equity:1416(2)(3)1(6)(21)
TOTAL LIABILITIES AND EQUITY:333356966

Income statement (P&L) ($ in millions)

9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
12/31/2014
Q4
9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
Revenues
(Revenue, Net)
0000000
Cost of revenue(0)(0)(0)(0)(0)(0)(0)
Other undisclosed gross profit (0) (0)(0)(0)(0)
Gross profit:0000000
Operating expenses(7)(7)(7)(7)(4)(16)(8)
Operating loss:(7)(7)(7)(7)(4)(16)(8)
Nonoperating income (expense)4(1)0001(1)
Other nonoperating income    0  
Interest and debt expense(0)(0)  (0)(0)(0)
Other undisclosed income from continuing operations before equity method investments, income taxes00  000
Loss from continuing operations before income taxes:(4)(7)(7)(7)(4)(16)(9)
Other undisclosed loss from continuing operations   (16)   
Net loss:(4)(7)(7)(23)(4)(16)(9)
Other undisclosed net income attributable to parent   16   
Net loss attributable to parent:(4)(7)(7)(7)(4)(16)(9)
Preferred stock dividends and other adjustments    (1)  
Net loss available to common stockholders, diluted:(4)(7)(7)(7)(4)(16)(9)

Comprehensive Income ($ in millions)

9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
12/31/2014
Q4
9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
Net loss:(4)(7)(7)(23)(4)(16)(9)
Comprehensive loss, net of tax, attributable to parent:(4)(7)(7)(23)(4)(16)(9)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: